Oslo-Norway and Utrecht-The Netherlands — Bayer AS has installed a state-of-the-art MILabs VECTor PET/SPECT/CT system to support its Targeted Alpha Therapy (TAT) platform of oncology projects. After its success with radium-223 dichloride (Xofigo), the first and only clinically approved targeted alpha therapy, Bayer is advancing an emerging class of novel targeted alpha therapies that combine […]
Clonality assurance assay and genetic stability analysis UTRECHT, THE NETHERLANDS – Cergentis, a genomics company that develops and commercializes kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, today announced the expansion of its product portfolio with new service packages for cell line development: clonality assurance package and genetic stability package. These […]
New CEO to steer the next stage of Axol Bioscience’s growth in the global iPSC stem cell markets Cambridge, UK: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam […]
IsoPlexis partners with Medquest to expand its single-cell proteomic analysis platform, the IsoLight system and IsoCode & CodePlex Chips, throughout the pharmaceutical and life science markets in Malaysia and Singapore BRANFORD, Conn. — IsoPlexis, the leader in single-cell proteomics products, today announced an exclusive agreement with Medquest, a company offering top-tier healthcare solutions to healthcare […]
With his international management experience and extensive network in various life science markets, Thomas Bachmann is a great asset to Cytosurge and will continue to develop its strategic future markets. Zurich | We are pleased to announce Thomas Bachmann as a new member of our Board of Directors. Thanks to his proven and long-standing strategic management experience […]
HAMPTON, N.J. — Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues in 3D such that they could move beyond traditional 2D histopathology and study tissues intact in their entirety. These products have now been used by over one thousand research labs, and in the last few […]
96-well Air / Liquid Interface (ALI) exposure / For reliable high throughput testing of cell cultures The VITROCELL® Cloud Alpha 96 is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines high throughput testing with ease of use. The development is based on the well-known and frequently […]
Longmont, CO – KromaTiD, Inc. announced today that it was awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural variant discovery platform – dGH DSCVR™ – enabling efficient discovery of genomic structural causes of rare disease and measurement of unwanted structural rearrangements […]
– Lonza to utilize of IsoPlexis’ IsoLight® automated proteomics platform – IsoLight® to be used for functional quality analytics for cell therapy products produced on Lonza’s Cocoon® Platform, an automated cell manufacturing platform BASEL, Switzerland and BRANFORD, Conn. Quote from Matthew Hewitt, Head of Clinical Development and Personalized Medicine, Lonza: “This collaboration between Lonza and IsoPlexis highlights the […]
Accomplished executive and scientist will lead company into next phase of commercial growth MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the appointment of Sander Gubbens, PhD, as its new CEO. Dr. Gubbens was most recently President of Gatan, which revolutionized the field of cryoEM with the breakthrough K2 electron […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
